[PDF] Top 20 Effect of ranolazine on HbA1c and blood glucose levels in diabetic patients with chronic angina

... 8 Ranolazine is a novel hemodynamically neutral antianginal and anti ischemic compound with cardioprotective properties and can be used both as monotherapy and as add on therapy when symptoms are not relieved with ... See full document

... 2 diabetic patients who met our inclusion criteria. These patients were then randomly divided into two Groups, A and ...B. Patients in Group A were treated as controls and they continued with ... See full document

... Keywords: Adiponectin, Angiotensin II, Diabetes, Hypoglycemia, PPAR a. Diabetes is usually caused by a complex interaction of genetics, environmental, inflammation and autoimmune factors. The metabolic dysregulation and ... See full document

... crevicular blood (GCB) for assessment of blood glucose level as a chairside test in the dental clinics and evalu- ate the influence of Phase I periodontal therapy on the glycemic control of ... See full document

... IDDM patients, compared to controls (siblings of the diabetics and non-related, nondiabetic patients) despite comparable plaque ...to-18-year-old diabetic patients and found no correlation ... See full document

... a normal Cortisol response to cosyntropin by 3 mo after the last ESI. Weekly ESI over 3 wk caused a dramatic acute and chronic suppression of the HPA axis. Median suppression was less than 1 mo, and all ... See full document

... complete blood count, blood urea nitrogen [BUN], serum calcium levels, arterial blood gas [ABG] analysis and urinalysis are carried ...infarction, chronic alcoholism, post operative ... See full document

... Lifestyle management though first line measure it is insufficient alone or there is difficulty in patient compliance, rendering the option conventional drug therapies i.e. oral hypoglycemic agents like insulin ... See full document

... glucagon levels. 19, 20 The hyperglycemic effect of tamsulosin should be further evaluated in other animals models of diabetes like streptozotocin induced diabetes rats and rabbits and models of type 2 ... See full document

... a chronic disorder caused by partial or complete insulin deficiency, which produces inadequate glucose control and leads to chronic ...these patients. Lower of blood glucose and ... See full document

... diabetes, glucose, ...by chronic hyperglycaemia with disturbances of carbohydrates, fat and protein metabolism owing to overproduction and / or underutilization of glucose ...impairs glucose ... See full document

... of patients with diabetes is increasing due to population growth, aging, urbanization and increasing prevalence of obesity and physical ...oral glucose-lowering drugs and insulin injection are the ... See full document

... a chronic disease in which food (particularly the nutrient – carbohydrate) is not properly absorbed in the body to be used as energy ...of chronic, diet-related non-communicable diseases such as obesity, ... See full document

... hypertensive patients who completed the study, ...hypertensive patients. These findings in patients on ARBs can be attributed to their PPAR gamma agonist activity which is partly responsible for its ... See full document

... LDL-C levels in sertraline-treated patients with depressive disorder did not significantly differ from pretreatment values, triglyceride levels significantly increased at the 8 th and 12 th ...on ... See full document

... the ranolazine branch represents the treat- ment using ranolazine as an add-on therapy for the symptomatic treatment of angina ...the patients to the treatment. Patients who do not ... See full document

... in HbA1c levels was achieved due to the reduction in TNF-a levels in the circulation in response to systemic doxycycline, which caused a decrease in periodontal infection and ...short-term ... See full document

... the levels of creatine phosphokinase is ...the levels of cardiac troponin T and troponin ...phosphokinase levels are elevated within four to eight hours and in about forty eight to seventy two hours ... See full document

... average angina frequency from weeks 2–8 of treatment Decreased MeRLiN-TiMi 3641Randomized, parallel, double-blind, placebo- controlled 3,2793,281ischemic symptoms at rest, presenting within 48 hours, at least one ... See full document

... of blood glucose is a prerequisite of tight glycemic control which will influence the treatment outcome of the ...for blood glucose is an invasive ...among patients of all ages and 27% ... See full document